Ludwig, H <br/><br/>
Suboptimal hemoglobin levels: do they impact patients and their therapy? Audience responses.  [electronic resource] 

 -  Seminars in oncology  Apr 2000 
 - 18-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Agents--adverse effects<br/>Blood Transfusion<br/>Epoetin Alfa<br/>Erythropoietin--therapeutic use<br/>Europe<br/>Evidence-Based Medicine<br/>Female<br/>Hematinics--therapeutic use<br/>Hemoglobins--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--complications<br/>Practice Patterns, Physicians'<br/>Quality of Life<br/>Recombinant Proteins<br/>Treatment Outcome<br/>United States